Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
Recruiting · NCT07481786 · Registry updated 2026-04-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases | Brain Metastases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenocarcinoma, brain disorder, carcinoma, central nervous system cancer, central nervous system disorder, epithelial neoplasm, lung adenocarcinoma, lung neoplasm, neoplasm, nervous system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-04-06 | NCT07481786 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sun Yat-sen University | 606 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing | China | 70 |
| The First Affiliated Hospital of Guangzhou University of Chinese Medicine | Guangzhou | China | 7 |